Organo-ID

Organo-ID develops organ-like structures to meet the clinical need for biomarkers to predict responsiveness to chemotherapy for cancer.

Company
Organo-ID
Category
HealthTech
Investment Vehicle
Fund I

About the company

Prof. Dr. Erdal and her team developed groups of cells that have organised themselves into organ-like structures to meet the clinical need for biomarkers to predict responsiveness to chemotherapy for cancer.